Anticancer Effect of Fucoidan in Combination with Tyrosine Kinase Inhibitor Lapatinib

Background. Despite a number of in vitro and in vivo studies reporting the efficacy of fucoidan in treating various cancers, few studies have measured the efficacy of dietary fucoidan (DF) in combination with cancer drugs. Thus, we examined the sensitivity of DF in combination with the EGFR/ERBB2-ta...

Descripción completa

Detalles Bibliográficos
Autores principales: Oh, Byeongsang, Kim, Jihun, Lu, Weidong, Rosenthal, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3920603/
https://www.ncbi.nlm.nih.gov/pubmed/24587811
http://dx.doi.org/10.1155/2014/865375

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3920603/
https://www.ncbi.nlm.nih.gov/pubmed/24587811
http://dx.doi.org/10.1155/2014/865375

Ejemplares similares